LabGenomics Co. Ltd (084650) — Capital Reinvestment Ratio
Latest as of December 2023:
0.18x
LabGenomics Co. Ltd (084650) has a Capital Reinvestment Ratio of 0.18x as of December 2023, meaning it reinvests 0% of its operating cash flow (₩4.96 Billion) in capital expenditures (₩895.50 Million). See free cash flow generation of LabGenomics Co. Ltd to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.18x
Capex / Operating Cash Flow
Operating Cash Flow
₩4.96 Billion
KRW
Capital Expenditures
₩895.50 Million
KRW
Data as of
Dec 2023
Most recent filing
LabGenomics Co. Ltd Capital Reinvestment Ratio (2014–2023)
This chart tracks LabGenomics Co. Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for LabGenomics Co. Ltd (2014–2023)
Year-by-year Capital Reinvestment Ratio for LabGenomics Co. Ltd from 2014 to 2023. For live market cap and broader valuation context, see market cap of LabGenomics Co. Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 2.15x | ₩2.42 Billion | ₩5.20 Billion | ▲ +291.1% |
| 2022 | 0.55x | ₩69.87 Billion | ₩38.33 Billion | ▲ +161.4% |
| 2021 | 0.21x | ₩65.36 Billion | ₩13.72 Billion | ▲ +1291.8% |
| 2020 | 0.02x | ₩46.37 Billion | ₩699.21 Million | ▼ -91.4% |
| 2019 | 0.18x | ₩3.19 Billion | ₩560.94 Million | ▼ -94.7% |
| 2018 | 3.33x | ₩608.03 Million | ₩2.03 Billion | ▲ +108.0% |
| 2016 | 1.60x | ₩2.54 Billion | ₩4.08 Billion | ▼ -17.6% |
| 2015 | 1.95x | ₩2.38 Billion | ₩4.63 Billion | ▲ +409.3% |
| 2014 | 0.38x | ₩3.15 Billion | ₩1.20 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow